ArticleNeurology2022

Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.

Jose-Alberto PalmaPubMed ↗Publisher ↗

No numbers read from the abstract.